| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.54 | 5e-07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.52 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.35 | 9e-25 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.34 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.34 | 4e-09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.32 | 6e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.32 | 3e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-22 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.3 | 4e-08 |